Collegium Pharmaceutical
COLL
eBay
EBAY
Halozyme Therapeutics
HALO
SilverCrest Metals
SILV
Workday
WDAY
(FY)Dec 31, 2018 | (Q4)Dec 31, 2018 | (Q3)Sep 30, 2018 | (Q2)Jun 30, 2018 | (Q1)Mar 31, 2018 | (FY)Dec 31, 2017 | (Q4)Dec 31, 2017 | (Q3)Sep 30, 2017 | (Q2)Jun 30, 2017 | (Q1)Mar 31, 2017 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -35.33%67.72M | -27.40%17.11M | -40.50%17.18M | -21.83%19.26M | -48.70%14.17M | 10.61%104.7M | 9.29%23.56M | 16.34%28.87M | -4.61%24.64M | 23.07%27.63M |
Operating revenue | -35.33%67.72M | -27.40%17.11M | -40.50%17.18M | -21.83%19.26M | -48.70%14.17M | 10.61%104.7M | 9.29%23.56M | 16.34%28.87M | -4.61%24.64M | 23.07%27.63M |
Cost of revenue | -33.35%65.9M | -29.12%16.31M | -40.91%16.14M | -21.11%18.65M | -40.60%14.79M | 11.31%98.88M | 12.18%23.01M | 20.07%27.31M | -1.57%23.65M | 15.57%24.9M |
Gross profit | -68.84%1.82M | 45.31%793.18K | -33.41%1.04M | -39.21%603.19K | -122.67%-618.56K | 0.04%5.82M | -47.64%545.87K | -24.65%1.56M | -45.11%992.21K | 201.66%2.73M |
Operating expense | -30.38%5.1M | -7.54%1.39M | -43.03%1.05M | -28.68%1.28M | -36.81%1.38M | -4.40%7.33M | -16.98%1.5M | -11.02%1.85M | -3.92%1.79M | 14.24%2.19M |
Selling and administrative expenses | -30.38%5.1M | -7.54%1.39M | -43.03%1.05M | -28.68%1.28M | -36.81%1.38M | -4.40%7.33M | -16.98%1.5M | -11.02%1.85M | -3.92%1.79M | 14.24%2.19M |
-Selling and marketing expense | -62.04%730.85K | -61.90%117.18K | -74.40%136.4K | -59.71%195.91K | -52.99%281.37K | 14.56%1.93M | -26.91%307.57K | 13.69%532.76K | 17.52%486.3K | 58.71%598.48K |
-General and administrative expense | -19.10%4.37M | 6.42%1.27M | -30.30%914.91K | -17.14%1.08M | -30.71%1.1M | -9.72%5.4M | -13.97%1.2M | -18.23%1.31M | -10.03%1.31M | 3.32%1.59M |
Operating profit | -118.41%-3.29M | 37.63%-598.12K | 95.12%-14.05K | 15.65%-676.25K | -468.30%-2M | 18.40%-1.51M | -24.54%-958.92K | -4,183.47%-287.68K | -1,245.48%-801.72K | 153.83%542.9K |
Net non-operating interest income expense | 22.77%-1.81M | -77.05%-662.09K | -39.02%-468.99K | 11.31%-307.35K | 70.97%-374.3K | -56.80%-2.35M | 8.13%-373.95K | 16.65%-337.35K | -5.63%-346.55K | -261.12%-1.29M |
Non-operating interest expense | -22.77%1.81M | 77.05%662.09K | 39.02%468.99K | -11.31%307.35K | -70.97%374.3K | 56.76%2.35M | -8.13%373.95K | -16.74%337.35K | 5.63%346.55K | 261.12%1.29M |
Other net income (expense) | 105.08%429.22K | -2,183.45%-8.45M | ||||||||
Special income (charges) | 105.08%429.22K | ---- | ---- | ---- | ---- | ---8.45M | ---- | ---- | ---- | ---- |
-Less:Impairment of capital assets | --0 | ---- | ---- | ---- | ---- | --8.45M | ---- | ---- | ---- | ---- |
-Less:Other special charges | ---429.22K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Income before tax | 62.03%-4.67M | 91.50%-830.99K | 22.72%-483.04K | 14.34%-983.59K | -218.00%-2.37M | -231.42%-12.3M | -731.06%-9.78M | -51.90%-625.03K | -3,414.96%-1.15M | 64.29%-746.48K |
Income tax | ||||||||||
Net income | 62.03%-4.67M | 91.50%-830.99K | 22.72%-483.04K | 14.34%-983.59K | -218.00%-2.37M | -231.42%-12.3M | -731.06%-9.78M | -51.90%-625.03K | -3,414.96%-1.15M | 64.29%-746.48K |
Net income continuous Operations | 62.03%-4.67M | 91.50%-830.99K | 22.72%-483.04K | 14.34%-983.59K | -218.00%-2.37M | -231.42%-12.3M | -731.06%-9.78M | -51.90%-625.03K | -3,414.96%-1.15M | 64.29%-746.48K |
Minority interest income | ||||||||||
Net income attributable to the parent company | 62.03%-4.67M | 91.50%-830.99K | 22.72%-483.04K | 14.34%-983.59K | -218.00%-2.37M | -231.42%-12.3M | -731.06%-9.78M | -51.90%-625.03K | -3,414.96%-1.15M | 64.29%-746.48K |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 62.03%-4.67M | 91.50%-830.99K | 22.72%-483.04K | 14.34%-983.59K | -218.00%-2.37M | -231.42%-12.3M | -731.06%-9.78M | -51.90%-625.03K | -3,414.96%-1.15M | 64.29%-746.48K |
Basic earnings per share | 72.88%-0.16 | 95.65%-0.02 | 33.33%-0.02 | 50.00%-0.03 | -100.00%-0.08 | -210.53%-0.59 | -666.67%-0.46 | -50.00%-0.03 | -3,594.58%-0.06 | 63.64%-0.04 |
Diluted earnings per share | 72.88%-0.16 | 95.65%-0.02 | 33.33%-0.02 | 50.00%-0.03 | -100.00%-0.08 | -210.53%-0.59 | -666.67%-0.46 | -50.00%-0.03 | -3,594.58%-0.06 | 63.64%-0.04 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unaudited | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |